A weekly GLP-1 injection is a medication taken once per week under the skin, commonly in areas such as the abdomen, thigh, or upper arm when instructed by a provider
This leads to the release of pro-inflammatory cytokines such as TNF-, IL-6, and IL-1
Published scientific literature has discussed BPC-157 and TB-500 in relation to peptide biology, molecular signaling pathways, protein interactions, extracellular matrix research, cellular communication models, and analytical peptide chemistry
Addressing iron status early prevents energy crashes that can derail adherence to your GLP-1 therapy
The senoreverse strategy has emerged as a transformative solution in the field, utilizing partial epigenetic reprogramming to reverse age-related genetic markers and restore cellular vitality at the molecular level
However, it would be interesting to see if similar bias occurs at central GLP-1r populations and whether this alters the synaptic and behavioral outcomes of GLP-1r agonism